Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2022-12-08
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products
Estimated value: 14671946 NOK
Award criteria: Lowest price

Technical requirements: Voluntary ex-ante transparency notice - Supplementary contracts for LIS 2301d ureg, ATC codes J05AF01, N05AX13, N05CD08, P01CX04, S01AX18, S01EE09 and V03AB13
Sykehusinnkjøp HF, Divisjon legemidler (LIS) is collecting tenders for medicines that are used by the Health Trusts. LIS has previously announced and held an open tender contest for Parenteral special pharmaceutical preparations (LIS 2301d). The contest includes active ingredients in accordance with the tender documentation, annex 3 - the Active Ingredients List.
Due to this, LIS intends to enter into contracts between the regional health trusts (the Contracting Authorities) and Nordic Pill AB (the Supplier) as a supplementary contract to LIS 2301d, i.e., the scope and length of the contract will follow the mentioned procurement (including access to extensions and terminations), without a new contest being held for this ingredient. The health trusts that are under the regional health authorities have options to join the contracts. The same applies for non-profit institutions/hospitals with an operational contract with each health region.
LIS has examined the market situation and is of the opinion that it is not possible to hold a new contest, or that a supplier other than Nordic Pill AB can deliver the product in this contract period, and that the situation that has occurred is not the contracting authority’s fault, nor something that the contracting authority could foresee. LIS [the Pharmaceutical Division] therefore believes that there are grounds to make the procurement without an invitation to tender. See the public procurement regulations §21-5, c.f. § 21-2, c.f. § 13-4 letter b no. 3 and letter cf. also § 13-3 letter e.
LIS requests that any objections to this contract award are submitted before the expiry of the waiting period, set to 10 days after the publication of the Voluntary ex ante transparency notice. If no objections are received, contracts will be signed after the waiting period has expired.
The requirement for a safety store for lot 128 will deviate from the requirements specification sa the product is an antidote with uneven sales.
LIS has examined the market situation and is of the opinion that it is not possible to hold a new contest, or that a supplier other than Nordic Pill AB can deliver the product in this contract period, and that the situation that has occurred is not the contracting authority’s fault, nor something that the contracting authority could foresee. LIS [the Pharmaceutical Division] therefore believes that there are grounds to make the procurement without an invitation to tender. See the public procurement regulations §21-5, c.f. § 21-2, c.f. § 13-4 letter b no. 3 and letter cf. also § 13-3 letter e.
The requirement for a safety store for lot 128 will deviate from the requirements specification sa the product is an antidote with uneven sales.


Winner: Nordic Pill AB
Award value: 14671946